253 related articles for article (PubMed ID: 14645693)
1. Expression of P-cadherin, but not E-cadherin or N-cadherin, relates to pathological and functional differentiation of breast carcinomas.
Kovács A; Dhillon J; Walker RA
Mol Pathol; 2003 Dec; 56(6):318-22. PubMed ID: 14645693
[TBL] [Abstract][Full Text] [Related]
2. E-cadherin expression correlates with histologic type but not tumour grade in invasive breast cancer.
Nurismah MI; Noriah O; Suryati MY; Sharifah NA
Asian Pac J Cancer Prev; 2008; 9(4):699-702. PubMed ID: 19256762
[TBL] [Abstract][Full Text] [Related]
3. Differential loss of E-cadherin expression in infiltrating ductal and lobular breast carcinomas.
Moll R; Mitze M; Frixen UH; Birchmeier W
Am J Pathol; 1993 Dec; 143(6):1731-42. PubMed ID: 8256859
[TBL] [Abstract][Full Text] [Related]
4. Reduced E-cadherin expression is associated with invasiveness and unfavorable prognosis in breast cancer.
Siitonen SM; Kononen JT; Helin HJ; Rantala IS; Holli KA; Isola JJ
Am J Clin Pathol; 1996 Apr; 105(4):394-402. PubMed ID: 8604681
[TBL] [Abstract][Full Text] [Related]
5. Cadherin-catenin complex dissociation in lobular neoplasia of the breast.
Morrogh M; Andrade VP; Giri D; Sakr RA; Paik W; Qin LX; Arroyo CD; Brogi E; Morrow M; King TA
Breast Cancer Res Treat; 2012 Apr; 132(2):641-52. PubMed ID: 22080244
[TBL] [Abstract][Full Text] [Related]
6. Breast carcinoma in sclerosing adenosis: a clinicopathological and immunophenotypical analysis on 206 lesions.
Yu BH; Tang SX; Xu XL; Cheng YF; Bi R; Shui RH; Tu XY; Lu HF; Zhou XY; Yang WT
J Clin Pathol; 2018 Jun; 71(6):546-553. PubMed ID: 29436376
[TBL] [Abstract][Full Text] [Related]
7. Solid low-grade in situ carcinoma of the breast: role of associated lesions and E-cadherin in differential diagnosis.
Maluf HM; Swanson PE; Koerner FC
Am J Surg Pathol; 2001 Feb; 25(2):237-44. PubMed ID: 11176073
[TBL] [Abstract][Full Text] [Related]
8. Differential expression of E-cadherin in lobular and ductal neoplasms of the breast and its biologic and diagnostic implications.
Acs G; Lawton TJ; Rebbeck TR; LiVolsi VA; Zhang PJ
Am J Clin Pathol; 2001 Jan; 115(1):85-98. PubMed ID: 11190811
[TBL] [Abstract][Full Text] [Related]
9. [Immunohistochemical study of P-cadherin in breast cancer].
Kovács A; Walker RA; Nagy A; Gomba S; Jones L; Dearing S
Orv Hetil; 2002 Feb; 143(8):405-9. PubMed ID: 11921707
[TBL] [Abstract][Full Text] [Related]
10. Invasive lobular breast cancer: the prognostic impact of histopathological grade, E-cadherin and molecular subtypes.
Engstrøm MJ; Opdahl S; Vatten LJ; Haugen OA; Bofin AM
Histopathology; 2015 Feb; 66(3):409-19. PubMed ID: 25283075
[TBL] [Abstract][Full Text] [Related]
11. The ductal phenotypic expression of the E-cadherin/catenin complex in tubulolobular carcinoma of the breast: an immunohistochemical and clinicopathologic study.
Esposito NN; Chivukula M; Dabbs DJ
Mod Pathol; 2007 Jan; 20(1):130-8. PubMed ID: 17143261
[TBL] [Abstract][Full Text] [Related]
12. Expression patterns of beta-catenin in in situ and invasive breast cancer.
Karayiannakis AJ; Nakopoulou L; Gakiopoulou H; Keramopoulos A; Davaris PS; Pignatelli M
Eur J Surg Oncol; 2001 Feb; 27(1):31-6. PubMed ID: 11237489
[TBL] [Abstract][Full Text] [Related]
13. P-cadherin expression in breast carcinoma indicates poor survival.
Peralta Soler A; Knudsen KA; Salazar H; Han AC; Keshgegian AA
Cancer; 1999 Oct; 86(7):1263-72. PubMed ID: 10506713
[TBL] [Abstract][Full Text] [Related]
14. Anomalous expression of P-cadherin in breast carcinoma. Correlation with E-cadherin expression and pathological features.
Palacios J; Benito N; Pizarro A; Suárez A; Espada J; Cano A; Gamallo C
Am J Pathol; 1995 Mar; 146(3):605-12. PubMed ID: 7534041
[TBL] [Abstract][Full Text] [Related]
15. Expression of c-erbB3 protein in primary breast carcinomas.
Naidu R; Yadav M; Nair S; Kutty MK
Br J Cancer; 1998 Nov; 78(10):1385-90. PubMed ID: 9823984
[TBL] [Abstract][Full Text] [Related]
16. Carcinomas in situ of the breast with indeterminate features: role of E-cadherin staining in categorization.
Jacobs TW; Pliss N; Kouria G; Schnitt SJ
Am J Surg Pathol; 2001 Feb; 25(2):229-36. PubMed ID: 11176072
[TBL] [Abstract][Full Text] [Related]
17. [Expression of Twist, E-cadherin and N-cadherin in breast carcinoma and their clinical significance].
Ma YH; Wang K; Li L; Lu ZH; Chen J
Zhonghua Bing Li Xue Za Zhi; 2010 Jan; 39(1):5-9. PubMed ID: 20388391
[TBL] [Abstract][Full Text] [Related]
18. P-cadherin and cytokeratin 5: useful adjunct markers to distinguish basal-like ductal carcinomas in situ.
Paredes J; Lopes N; Milanezi F; Schmitt FC
Virchows Arch; 2007 Jan; 450(1):73-80. PubMed ID: 17123107
[TBL] [Abstract][Full Text] [Related]
19. Loss of the tight junction protein claudin-7 correlates with histological grade in both ductal carcinoma in situ and invasive ductal carcinoma of the breast.
Kominsky SL; Argani P; Korz D; Evron E; Raman V; Garrett E; Rein A; Sauter G; Kallioniemi OP; Sukumar S
Oncogene; 2003 Apr; 22(13):2021-33. PubMed ID: 12673207
[TBL] [Abstract][Full Text] [Related]
20. Expression of E-cadherin and catenins in invasive mammary carcinomas.
Zschiesche W; Schönborn I; Behrens J; Herrenknecht K; Hartveit F; Lilleng P; Birchmeier W
Anticancer Res; 1997; 17(1B):561-7. PubMed ID: 9066580
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]